GT Biopharma Inc. Common Stock — Rendiconto Finanziario Trimestrale (NASDAQ:GTBP) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 11.99 M
Employee 1
Founded N/A
CEO N/A
Website www.gtbiopharma.com
Headquarter Delaware, United States
FIGI BBG000DHJ738
Industry Biotecnologia

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

11.99 M Capitalizzazione di mercato

Notizie

GT Biopharma stipula accordo con l’Università del Minnesota per trial di fase 1

GT Biopharma rivedrà i dati finanziari 2025 per errore contabile sui Diritti Greenshoe

GT Biopharma to restate 2025 financials after error in Greenshoe Rights accounting

GT Biopharma presenta domanda IND per trattamento del cancro a tumori solidi

GT Biopharma submits IND application for solid tumor cancer treatment

EXCLUSIVE: GT Biopharma Plans 2026 Trial For New Cancer Treatment - GT Biopharma (NASDAQ:GTBP)

Azioni GT Biopharma in rialzo con l’avanzamento della sperimentazione di Fase 1

GT Biopharma stock rises as Phase 1 trial advances to higher dose

Why Quantum Computing Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Cycurion (NASDAQ:CYCU), Clearwater Analytics Hldg (NYSE:CWAN)

GT Biopharma advances to Cohort 4 in Phase 1 trial of cancer therapy

Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Apogee Therapeutics (NASDAQ:APGE), Ambow Education Holding (AMEX:AMBO)

EXCLUSIVE: GT Biopharma Reports Progresses Phase 1 Trial Of Lead Drug Candidate For Blood Cancers - GT Biopharma (NASDAQ:GTBP)